Financial Results, Fraud Risk Report, Updated Technology, Private Label Segment Report and Partnerships - Research Report on priceline.com, Alliance Data, Cardtronics, Verisk, and athenahealth PR Newswire NEW YORK, November 25, 2013 NEW YORK, November 25, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting priceline.com Incorporated (NYSE: PCLN), Alliance Data Systems Corporation (NYSE: ADS), Cardtronics Inc. (NASDAQ: CATM), Verisk Analytics, Inc. (NASDAQ: VRSK), and athenahealth, Inc. (NASDAQ: ATHN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. priceline.com Incorporated Research Report On November 19, 2013, priceline.com Incorporated (priceline.com) announced a new beta version of its iPad app that brings travel exploration, research and booking capabilities together in one interface. According to priceline.com, its new Explore functionality unhinges travel aspirations and empowers consumers to discover new popular priceline.com destinations around the world, while comparing prices, reducing the need to research and book travel at different times in different places. "Our iPad customers are in the early stages of travel planning, often booking further in advance for longer lengths of stay compared to smartphone users. In fact, iPad users are almost three times more likely to book 10+ days in advance than iPhone users," said John Caine, Chief Product Officer of priceline.com. "We've designed this feature for iPad users by making it easier to research multiple destinations, and we are delighted to help travelers who are just beginning the exploration process." The Full Research Report on priceline.com Incorporated - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/8186_PCLN -- Alliance Data Systems Corporation Research Report On November 15, 2013, Alliance Data Systems Corporation (Alliance Data) provided a performance update on its Private Label segment. Alliance Data informed that average receivables of the Company during October 2013 stood at $7.4 billion, up 14% YoY. Net charge-offs were $31.4 million or 5.1% as a percentage of average receivables. The Company informed that in conjunction with the release of its Master Trust Monthly Noteholder's Statement, Alliance Data is also releasing similar metrics for the overall total managed portfolio. The Full Research Report on Alliance Data Systems Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/bf7b_ADS -- Cardtronics Inc. Research Report On November 4, 2013, Cardtronics Inc. (Cardtronics) reported its financial results for Q3 2013. Total revenue increased 15.0% YoY to $228.8 million during the quarter. Net loss attributable to controlling interests and available to common stockholders was $8.4 million or $0.19 per diluted share in Q3 2013, compared to net income attributable to controlling interests and available to common stockholders of $12.9 million or $0.28 per diluted share in Q3 2012. Cardtronics' CEO, Steve Rathgaber, commented, "We had another strong quarter, which was highlighted by the completion of our largest acquisition to date, which significantly expanded our European operations. We were very pleased with the early returns from this investment, which was included in our results for just under two months in the third quarter. Our third quarter results also reflect our continued success in leveraging our revenue growth into strong bottom line earnings growth, which was up 28% on an adjusted per share basis." The Full Research Report on Cardtronics Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/6004_CATM -- Verisk Analytics, Inc. Research Report On November 20, 2013, Verisk Analytics, Inc.'s subsidiary, Interthinx, announced the release of its quarterly interactive Mortgage Fraud Risk Report, covering data collected in Q3 2013. The Company informed that during Q3 2013, the national Mortgage Fraud Risk Index valued at 108, indicating an increase of 10% YoY. According to the Company, the quarterly findings of the report also highlighted higher jumbo loan index values across all type-specific fraud risks, with striking difference in the employment/income fraud risk index, where the index value for jumbo loans stood at 146, against a value of 69 for non-jumbo loans. "With the rise in popularity of jumbo loans, lenders must be aware of both the credit risk and fraud risk those loans carry," said Ashley Woodworth, Interthinx's Vice President of Business Development and Corporate Strategy. "While the most significant fraud risk gap occurred in the area of employment/income, it certainly wasn't the only area where risk was present. Occupancy fraud risk for jumbos, for example, was extremely high - more than 200 by our index versus 150 for non-jumbo loans. The risk is out there, and lenders need to be aware." The Full Research Report on Verisk Analytics, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/54f1_VRSK -- athenahealth, Inc. Research Report On November 14, 2013, athenahealth, Inc.'s subsidiary, Epocrates, Inc. (Epocrates), announced a partnership with The Cochrane Library to bring selections of its internationally recognized evidence-based reviews, editorials and meta-analyses to the Epocrates Rx application, further informing the clinical choices made by health care providers. "This is a real win for our million-plus clinician members," said Dr. Anne Meneghetti, Executive Director of Medical Information for Epocrates. "Cochrane has earned its place as a highly respected source by examining bodies of evidence in specific areas, such as the accuracy of a diagnostic test for a specific patient population. I believe it challenges common patterns of care and shines a light on evidence behind commonly held practices, so clinicians can apply optimal judgment in the moments of care." The Full Research Report on athenahealth, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/501f_ATHN ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Namrata Maheshwari, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Namrata Maheshwari, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AnalystsCorner.com SOURCE Analysts' Corner Contact: CONTACT PERSON: Joe Thomas CONTACT PHONE: +1-310-496-8071 (North America)
Financial Results, Fraud Risk Report, Updated Technology, Private Label Segment Report and Partnerships - Research Report on
Press spacebar to pause and continue. Press esc to stop.